⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RVMD News
Revolution Medicines, Inc. Common Stock
Levi & Korsinsky Urges Erasca, Inc. (ERAS) Shareholders to Act Before Lead Plaintiff Deadline August 10, 2026
accessnewswire.com
ERAS
RVMD
Recover Investment Losses: Class Action Initiated Against Erasca, Inc. (ERAS)
accessnewswire.com
ERAS
RVMD
Investor Alert: Deadline Approaching to Join Erasca, Inc. (ERAS) Class Action – Contact Levi & Korsinsky
accessnewswire.com
ERAS
RVMD
Levi & Korsinsky Urges Erasca, Inc. (ERAS) Shareholders to Act Before Lead Plaintiff Deadline August 10, 2026
accessnewswire.com
ERAS
RVMD
ERAS LAWSUIT ALERT: Levi & Korsinsky Notifies Erasca, Inc. Investors - Lead Plaintiff Deadline August 10, 2026
accessnewswire.com
ERAS
RVMD
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
globenewswire.com
RVMD
ERAS ALERT: Securities Fraud Class Action Launched Against Erasca, Inc. - August 10, 2026 Deadline
accessnewswire.com
ERAS
RVMD
Investor Alert: Deadline Approaching to Join Erasca, Inc. (ERAS) Class Action - Contact Levi & Korsinsky
accessnewswire.com
ERAS
RVMD
Recover Investment Losses: Class Action Initiated Against Erasca, Inc. (ERAS)
accessnewswire.com
ERAS
RVMD
Investor Alert: Deadline Approaching to Join Erasca, Inc. (ERAS) Class Action - Contact Levi & Korsinsky
accessnewswire.com
ERAS
RVMD